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Purpose: The purpose of this study was to examine the effect of peripheral vascular disease 
(PVD) on in-hospital mortality rates after coronary artery bypass grafting (CABG). 
Methods: We performed a regional cohort study of 3003 patients undergoing CABG 
between 1987 and 1989 at five tertiary care centers in Maine, New Hampshire, and 
Vermont. Data reflecting patient characteristics, severity of heart disease, comorbidity, and 
in-hospital mortality rates were collected prospectively; the presence of clinical and 
subclinical indicators of PVD was determined retrospectively. 
Results: Observed in-hospital mortality rates with CABG were 2.4-fold higher in the 796 
patients with indicators of PVD (7.7%) than in the 2207 patients without PVD (3.2%) 
(crude odds ratio [OR] 2.42 [95% confidence interval (CI) 1.73-3.37]). After adjusting 
for their higher comorbidity scores, more advanced heart disease, and age, patients with 
PVD remained 73% more likely to die in hospital after CABG (adjusted OR 1.73 [CI 
1.19-2.51]). The excess risk of in-hospital death associated with PVD was attributable 
largely to lower extremity occlusive disease (adjusted OR 2.03 [CI 1.34-3.07]). 
Subclinical lower extremity occlusive disease (asymptomatic absence of pedal pulses) had 
the same effect as clinically overt disease. Cerebrovascular disease had a small and 
statistically nonsignificant effect on CABG-related deaths (adjusted OR 1.13 [CI 
0.73-1.74]). Excess mortality rates in patients with PVD were primarily due to increased 
risk of death from heart failure and dysrhythmias, but not to cerebrovascular accidents or 
peripheral arterial complications. 
Conclusions: The presence of lower extremity arterial occlusive disease is an important, 
independent predictor of in-hospital mortality rates for patients undergoing CABG. 
Controlled studies of the long-term effects of CABG in patients with PVD are needed to 
determine the optimal role of myocardial revascularization in this population. (J VAse 
SURG 1995;21:445-52.) 
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Patients with peripheral vascular disease (PVD) 
have a high prevalence of coronary artery disease 
and frequently undergo coronary artery bypass 
grafting (CABG). 1 Both clinical experience and 
published studies suggest that this group of pa- 
tients may have higher perioperative mortality 
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rates with this procedure than have patients without 
PVD. Noncontemporaneous series from the Cleve- 
land Clinic revealed substantially higher rates of 
CABG-related eaths for patients with PVD. 2,3 More 
recently, subgroup analyses of several large studies 
assessing preoperative risk factors have demonstrated 
that the presence of PVD increases operative mor- 
tality rates with CABG by 1.6- to 2.9-fold. 46 
Although the association between PVD and 
increased mortality rates with CABG is generally 
recognized, no large study has specifically addressed 
this relationship. Among many remaining issues, the 
role of confounding variables, such as advanced age, 
comorbidity, or more advanced heart disease in 
patients with PVD, has not been fially explored. Fur- 
thermore, PVD represents a heterogeneous group of 
clinical and pathophysiologic conditions. It is not 
known whether the effect of PVD on mortality rates 
after CABG differs by anatomic location (e.g., 
cerebrovascular vs lower extremity occlusive disease) 
or clinical status, such as the presence of symptoms. 
Finally, it is not known whether increased in-hospital 
mortality rates with CABG in patients with PVD can 
be attributed to specific causes of death. 
To address these questions, we performed a
regional cohort study of patients undergoing CABG 
in northern New England between 1987 and 1989. 
METHODS 
Subjects and data collection. The Northern 
New England Cardiovascular Disease Study Group is 
a voluntary research consortium representing all five 
hospitals in Maine, New Hampshire, and Vermont 
where CABG is performed. Since 1987, the North- 
ern New England Cardiovascular Disease Study 
Group has maintained a prospective registry of all 
patients undergoing isolated CABG in the region. 
The registry excludes patients undergoing CABG 
incidental to heart valve repair, resection ofventricu- 
lar aneurysm, or another surgical procedure. We 
based this analysis on 3055 consecutive patients 
undergoing surgery between July 1, 1987, and April 
15, 1989; data collection methods and definitions, 
patient characteristics, and determinants of periop- 
erative death in this subgroup have been described 
previously in detail. 6'7 
The following data were recorded prospectively 
for all patients: patient age and sex, body surface area, 
cardiac catheterization results (degree of left main 
coronary artery stenosis, total number of significantly 
diseased vessels, left ventricular end-diastolic pressure 
[LVEDP], and ejection fraction), presence ofcomor- 
bidity, prior CABG (yes or no), and priority of 
surgery (emergent, urgent, or elective). The ejection 
fraction results were scored according to the method 
described by Pierpont et al. s Cardiac catheterization 
reports, available for 94.4% of patients, were re- 
viewed by an independent committee consisting of 
four research assistants, two physicians, and the 
cardiologist performing the catheterization. The 
number of diseased coronary vessels was assessed 
according to criteria established by the National 
Heart, Lung, and Blood Institute Coronary Artery 
Surgery Study. 9 CABG was defined as emergent 
when medical factors relating to the patient's heart 
disease dictated that surgery be performed within 
hours to prevent morbidity or death. Urgent CABG 
was defined by the presence of clinical factors 
requiring that the patient stay in the hospital to 
undergo the operation before discharge. The remain- 
ing cases were defined as elective. 
The presence of comorbidities, including chronic 
obstructive lung disease (COPD), preexisting renal 
disease, diabetes with and without sequelae, cancer, 
liver disease with and without Sequelae, dementia, 
preexisting peptic ulcer disease, and hypertension 
were obtained from hospital discharge data. For this 
analysis, retrospective r view of medical records was 
performed to confirm the presence or absence of 
COPD, insulin- and non-insulin-dependent diabetes, 
and hypertension and to assess tobacco use. To 
account for coexisting illnesses in multivariate anal- 
ysis, we compiled a comorbidity index for each 
patient according to methods described by Charlson 
et al) ° To assess the role of PVD as an independent 
risk factor, we used a modified Charlson score that 
omitted the contribution of PVD. 
The presence or absence of PVD in each patient 
was determined retrospectively b review of medical 
records. Information was abstracted by trained chart 
reviewers (all nurses) at each of the five centers. 
Reviewers were instructed to rely solely on informa- 
tion provided in admission (history and physical) 
notes recorded uring hospitalization for CABG and 
before surgery. Evidence of PVD noted after the 
CABG operation and at later hospitalizations was not 
included. Evidence of PVD recorded in previous 
hospitalizations was also not included, with one 
exception: admission otes from transferring insti- 
tutions were allowed in unusual circumstances in 
which admission otes by personnel of the center 
performing the CABG were not available. 
We collected the following indicators of PVD: 
prior cerebrovascular ccident (CVA), history of 
transient ischemic attack(s) (TLAs) or amaurosis 
fugax, prior carotid endartectomy, carotid stenosis 
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Table I. Prevalence of PVD and death in 3003 patients undergoing CABG 
Prevalence In-hospital deaths 
n % n % 
No PVD 2207 73.5 70 3.2 
PVD overall 796 26.5 61 7.7 
CABG before planned vascular surgery 20 0.7 5 25.0 
History of CVA 105 3.5 8 7.6 
History of TIA 98 3.3 5 5.1 
Prior carotid endarterectomy 108 3.6 8 7.4 
Carotid stenosis 
By history alone 28 0.9 1 3.6 
Known > 50% by imaging study 78 2.6 6 7.7 
Carotid bruit 334 11.1 27 8.1 
History of claudication 238 7.9 19 8.0 
Prior lower extremity revascularization 82 2.7 6 7.3 
Prior amputation (nontraumatic) 16 0.5 7 43.7 
Lower extremity arterial ulcer 13 0.4 1 7.7 
Absent pedal pulses 
Unilaterally 103 3.4 7 6.8 
Bilaterally 180 6.0 26 14.4 
Abdominal aortic aneurysm 
Surgically repaired 26 0.9 3 11.5 
Not repaired 31 1.0 2 6.5 
(by history or radiographically documented), carotid 
bruit, claudication, prior lower extremity vascular 
bypass (and type), prior lower extremity amputation 
(nontraumatic), presence or absence of palpable 
pedal pulses (considered present if either the dorsal 
pedal or posterior tibial artery was recorded as 
palpable), and abdominal aortic ancurysm (repaired 
or not repaired). When not documented in the 
medical record, carotid bruits (7% missing) were 
classified as absent and pedal pulses (9% missing) 
were considered palpable. Similarly, other clinical 
indicators of PVD were considered absent if not 
mentioned explicitly in the preoperative r cord. The 
medical records of 52 of the 3055 patients could not 
be located to assess PVD status; this analysis was 
based on the remaining 3003 patients. 
In-hospital deaths occurring during the admis- 
sion for CABG were recorded prospectively by the 
individual surgeons and verified with hospital dis- 
charge data from each center. There were 131 deaths 
among 3003 patients, a 4.4% crude mortality rate. 
Of the 52 patients excluded from the analysis because 
of missing medical records, there were three deaths. 
Cause of death was assigned by a clinical end points 
committee. I1 Six categories were defined: bleeding, 
dysrhythmias, cardiac failure (including periopera- 
tive myocardial infarctions), primary respiratory 
failure, neurologic event, and other. 
Analysis. Standard statistical methods were used 
to describe the prevalence of PVD and to compare 
the characteristics of patients with and without PVD. 
We used logistic regression analysis to quantify the 
effect of PVD on in-hospital mortality rates (ex- 
pressed in terms of odds ratios [ORs], which approxi- 
mate relative risk) and to adjust for potentially con- 
founding variables in multivariate analysis. These 
variables included patient age, sex, body surface area, 
comorbidity index, prior CABG, LVEDP, ejection 
fraction score, and priority of surgery and have been 
described previously as important determinants of
in-hospital death after CABG. 6 Analysis was per- 
formed with SAS and the SAS PROC LOGIST pro- 
grams (SAS Institute Inc., Cary, N.C., 1986). 
RESULTS 
Of 3003 patients undergoing CABG, 796 pa- 
tients (26.5%) had at least one indicator of PVD and 
2207 patients (73.5%) did not. Table I summarizes 
the prevalence of various indicators of PVD. Com- 
pared with patients without indicators of PVD, 
patients with PVD, particularly those with cere- 
brovascular disease, were older and more likely to be 
women (Table II). The highest proportions of 
women were noted in patients with subclinical PVD. 
For example, 41% of patients with asymptomatic 
carotid stenosis or bruits were women, compared 
with 29% of patients with prior CVAs, TIAs, or 
carotid endartectomy (to = 0.02). Similarly, 37% of 
patients with asymptomatic absence of pedal pulses 
were women, compared with 29% of patients with 
histories of claudication, lower extremity revascular- 
ization, or amputation (p = 0.15). 
JOURNAL OF VASCULAR SURGERY 
448 Birkmeyer et al. March 1995 
Table II. Characteristics of patients undergoing CABG according to presence or absence of PVD 
PVD 
Cerebrovascular Lower extremity 
No PVD alone alone Both 
(n = 2207) (n = 326) (n = 269) (n = 161) p Value* 
Patient age (mean yr) 61.9 
Patient sex (% female) 24.7 
Body surface area (mean m 2) 1.94 
Comorbidity index (mean) 0.25 
Diabetes (% yes) 16.3 
COPD (% yes) 4.5 
Hypertension (%yes) 48.2 
Current or recent cigarette smoking (% yes) 27.1 
Prior CABG (% yes) 5.2 
Ejection fraction (%) 58.1 
LVEDP (ram Hg) 18.3 
Poor cardiac function (% yes) (ejection frac- 3.2 
tion < 40% and LVEDP > 20 mm Hg) 
Priority of surgery (%) 
Elective 52.9 
Urgent 40.5 
Emergent 6.6 
Left main coronary artery stenosis _> 50% 18.4 
(% yes) 
No. of diseased coronary vessels (mean) 2.39 
No. of distal anastomoses (mean) 3.02 
Preoperative intravenous nitroglycerin 19.9 
(% yes) 
Preoperative intraaortic balloon pump 5.2 
(% yes) 
67.0 63.8 66.3 < 0.001 
33.7 29.7 39.1 <0.001 
1.86 1.92 1.84 < 0.001 
0.28 0.42 0.42 < 0.001 
18.1 28.6 29.2 <0.001 
7.1 8.9 9.3 <0.001 
63.5 57.6 64.0 < 0.001 
25.2 36.4 32.3 <0.001 
6.8 10.0 9.9 <0.01 
57.8 53.9 57.8 <0.01 
19.7 20.6 17.8 < 0.001 
2.8 6.0 1.2 0.57 
48.8 49.1 39.1 <0.01 
45.1 43.5 54.0 <0.01 
6.1 7.4 6.8 0.97 
24.5 24.9 36.0 < 0.001 
2.56 2.45 2.54 <0.001 
3.15 3.0 3.03 0.06 
20.7 26.0 24.2 0.04 
4.0 7.2 4.6 0.92 
*Comparisons between patients with PVD and patients without PVD. 
Patients with PVD had more comorbidity and 
markers of  more severe heart disease (Table II). Mean 
comorbidity scores were substantially higher in 
patients with PVD than in patients without PVD 
indicators, largely because of higher prevalence rates 
of diabetes in patients with lower extremity occlusive 
disease. Patients with PVD also had slightly higher 
prevalences of COPD, hypertension, and current or 
recent cigarette smoking (Table I1). There was a 
modest but statistically significant trend toward 
poorer left ventricular function in patients with PVD, 
as assessed by ejection fraction and LVEDP. Patients 
with PVD also had evidence of more advanced 
coronary disease, including higher prevalence of left 
main coronary disease and greater numbers of 
diseased coronary vessels. Patients with PVD were 
more likely to have undergone prior CABG and to 
require urgent rather than elective surgery. Most 
differences between the characteristics of patients 
with and without PVD were statistically significant at 
thep < 0.01 level (Table II). 
In-hospital mortal ity rates. The in-hospital 
mortality rate was 2.4-fold higher in patients with 
PVD (7.7%) than in patients without evidence of 
PVD (3.2%) (crude OR 2.42; 95% confidence 
interval [CI] 1.73-3.37) (Table III). Higher rates of 
in-hospital deaths after CABG were generally con- 
sistent across different indicators of PVD (Table I). 
Especially high perioperative mortality rates were 
observed in the small number of  patients undergoing 
CABG before a planned peripheral vascular proce- 
dure (5 of 20; 25%) and in patients with prior lower 
extremity amputations (7 of 16; 43%). Increased 
mortality rates were seen in patients with docu- 
mented carotid bruits (8.1%) or absent pedal pulses 
(unilateral 6.8%; bilateral 14.4%), rates similar to 
those observed in patients with indicators of symp- 
tomatic PVD. For the 7% and 9% of patients for 
whom the presence or absence of bruits and pedal 
pulses, respectively, was not documented, in-hospital 
mortality rates were similar to those seen in patients 
without PVD. 
Because patients with and without PVD differed 
with respect o many variables that also influence 
perioperative mortality rates, we used multivariate 
analysis to assess the role of PVD as an independent 
risk factor. After simultaneously adjusting for age, 
sex, body surface area, ejection fraction, LVEDP, 
surgical priority, prior CABG, and comorbidity 
score, PVD remained a significant risk factor for 
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Fig. 1. Column graph compares incidence rates of different causes of in-hospital death with 
CABG in patients with (dark shading) and without PVD (light shading). 
Table III. Crude and adjusted ORs of in-hospital deaths with CABG associated with PVD 
Category (n) 
OR of in-hospital deaths 
Crude (95% CI) Adjusted (95% CI) ~ 
Any PVD (796) 
Cerebrovascular disease alone (326) 
Clinical (153) (Prior CVA, TIA, or carotid endarterectomy) 
Subclinical (173) (asymptomatic carotid bruit or stenosis) 
Lower extremity occlusive disease alone (269) 
Clinical (159) (claudication, prior amputation, or lower ex- 
tremity revascularization) 
Subclinical (110) (asymptomatic absence of pedal pulses, uni- 
lateral or bilateral) 
Both cerebrovascular and lower extremity occlusive disease (161) 
2.42 (1.73-3.37) 1.73 (1.19-2.51) 
1.48 (0.97-2.24) 1.13 (0.73-1.74) 
1.36 (0.78-2.37) 1.06 (0.60-1.88) 
1.59 (0.94-2.70) 1.19 (0.68-2.09) 
2.64 (1.77-3.93) 2.03 (1.34-3.07) 
2.31 (1.42-3.74) 1.90 (1.15-3.15) 
3.24 (1.88-5.55) 2.22 (1.25-3.96) 
3.90 (2.69-5.66) 2.29 (1.72-3.04) 
~Based on a multivariate logistic regression model including age, sex, body surface area, ejection fraction, LVEDP, modified Charlson 
comorbidity index, prior CABG, cerebrovascular disease, and lower extremity occlusive disease) Note: 95% confidence intervals 
overlapping 1.0 indicate p > 0.05. 
in-hospital death (adjusted OR 1.73; CI 1.19-2.51). 
Because the crude OR of in-hospital death was 
calculated to be 2.42, increased age and other 
confounding variables accounted for approximately 
half of the increased risk associated with PVD. 
In subgroup analysis, the effect of PVD on 
in-hospital death was found to be attributable argely 
to increased risks in patients with lower extremity 
occlusive disease (Table III). After adjustment for 
confounding variables, lower extremity occlusive 
disease was associated with an approximately twofold 
increased risk of CABG-related eath (adjusted OR 
2.03; CI 1.34-3.07). Of note, asymptomatic absence 
of pedal pulses had an effect on in-hospital mortality 
rates (adjusted OR 2.22; CI 1.25-3.96) similar to 
that of clinically overt disease (claudication, prior 
amputation, or lower extremity revascularization 
[adjusted OR 1.90; CI 1.15-3.15]). Conversely, the 
presence of clinical or subclinical cerebrovascular 
disease alone had negligible effect on risks of in- 
hospital death after CABG (Table III). 
Cause of death. Excess in-hospital mortality rates 
after CABG in patients with PVD were primarily due 
to cardiac causes (Fig. 1). Compared with patients 
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without PVD, patients with PVD had substantially 
higher rates of death from heart failure (3.9% vs 
1.6%;p < 0.001), accounting for 50% of the overall 
difference in mortality risk. Deaths as a result of 
dysrhythmias were also more common among pa- 
tients with PVD (2.0% vs 0.4%; p < 0.001) and 
represented 35% of the overall difference in risk. The 
presence of PVD was not associated with increased 
rates of fatal neurologic events or death from 
miscellaneous causes (which would include periph- 
eral arterial complications). 
DISCUSSION 
Patients with PVD are substantially more likely 
(2.4-fold) to die in hospital after CABG. Although 
previous authors have made similar observa- 
tions, 4'5'6'12 this is the first large study to address 
specifically the relationship between PVD and peri- 
operative death during this commonly performed 
procedure. As expected, patients with PVD were 
older, had more comorbidity, and had more ad- 
vanced heart disease than had patients without PVD. 
However, the presence of PVD remained a strong 
independent risk factor for in-hospital death during 
CABG even after adjustment for these variables. In 
subgroup analysis, we found the excess risks associ- 
ated with PVD to be largely attributable to lower 
extremity occlusive disease. Among patients with 
lower extremity occlusive disease, risks were as high 
in patients with subclinical disease as in patients with 
overt disease. Asymptomatic absence of pedal pulses 
unilaterally or bilaterally increased the likelihood of 
in-hospital death during CABG by 2.2-fold, after 
adjusting for confounding variables. 
Despite positive findings by previous investiga- 
tors, 4,5 we did not demonstrate a clinically or 
statistically significant association between cere- 
brovascular disease, symptomatic or asymptomatic, 
and in-hospital death with CABG. Reasons for the 
difference are uncertain, but incomplete accounting 
for confounding variables in previous tudies may be 
one explanation. In our data, increased observed 
deaths in patients with any indicator of cerebrovas- 
cular disease (6.8%; OR 2.14 vs patients without 
PVD) were attributable argely to deaths in patients 
with coexistent lower extremity occlusive disease. 
Adjusting for this confounder reduced the OR of 
deaths associated with cerebrovascular disease sub- 
stantially (OR 1.45). Adjusting for other covariates, 
particularly increased age, made tile effect of cere- 
brovascular disease alone almost negligible (OR 
1.13). Although cerebrovascular disease may not 
substantially increase mortality rates, it has been 
shown by some investigators to affect morbidity after 
CABG. ~ We did not have sufficient information on 
nonfatal clinical outcomes, including perioperative 
stroke, to explore this relationship in our patient 
population. 
The primary reasons for the association between 
PVD and increased risk of in-hospital death with 
CABG remain tmcertain. Most of the excess deaths 
were attributable tocardiac auses: myocardial failure 
and dysrhythmias. Compared with patients without 
PVD, patients with PVD had evidence of only mod- 
esty decreased left ventricular function, as deter- 
mined by preoperative ejection fraction and LVEDP. 
Severity of heart disease, assessed by number of dis- 
eased vessels and number of distal coronary anasto- 
moses, was also only slightly worse in patients with 
PVD. Although previous analyses by these authors 6 
have not found the number of diseased coronary ar- 
teries to be an independent predictor of in-hospitality 
deaths with CABG, standard eterminations of num- 
ber of diseased coronary vessels may not assess ever- 
ity of distal coronary disease or "microvascular" dis- 
ease adequately. Thus a higher prevalence ofunrecon- 
structible distal heart disease in patients with PVD 
may be one plausible xplanation for their increased 
risk of in-hospital cardiac-related death after CABG. 
This hypothesis could be tested readily by further 
studies that use quantitative angiographic tech- 
niques. A second explanation for increased mortality 
rates may be the relationship between PVD and fatal 
atheroembolism from the ascending aorta during 
CABG. 13 Coronary atheroembolism has been de- 
scribed as a cause of perioperative myocardial infarc- 
tion. 14 We did not, however, find substantially in- 
creased rates of fatal peripheral theroembolism , such 
as CVAs, vascular-related abdominal catastrophes, or 
lower extremity ischemia, in patients with PVD. 
It is important o consider the strengths and 
limitations of this study. The regional, multiinstitu- 
tional nature of the study reduces the potential for 
selection or referral bias in our results. Because 
patient demographics, comorbidity, and severity of 
heart disease were recorded prospectively, it is also 
unlikely that the strong association between indica- 
tors of PVD and increased CABG-related eaths can 
bc attributed to bias in the measurement of poten- 
tially confounding variables. There are, however, two 
potential biases originating from the retrospective 
collection of information on PVD status. The first is 
random misclassification fPVD status, in either the 
original medical record or the process of chart review. 
The detail of preoperative history taking and physical 
examination before CABG no doubt varies substan- 
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tially and the documentation f signs and symptoms 
of PVD contains inevitable rrors. Thus patients with 
PVD are sometimes categorized aswithout PVD and 
(to a lesser extent) vice versa. Such misclassification f
PVD creates a bias toward the null hypothesis (i.e., 
contributes to underestimation f the true effect of 
PVD on in-hospital mortality rates with CABG). A 
second potential source of bias would be systematic 
differences in the detail of PVD documentation in 
patients dying after CABG. To avoid this bias, we 
restricted the source of information on PVD status to 
the preoperative admission ote(s) of the hospital- 
ization for CABG. 
Mthough we have examined the effect of PVD on 
the perioperative risks of CABG, it is important to 
consider the potential effect of PVD on the long-term 
benefit of this procedure. The high rates of cardiac- 
related eaths observed in patients with PVD are not 
completely corrected with myocardial revasculariza- 
tion. Among patients undergoing CABG, patients 
with PVD have consistently higher long-term mor- 
tality rates than have patients without PVD. In the 
Coronary Artery Surgery Study, 8-year survival rates 
for patients with PVD (68% to 71%) were signifi- 
cantly lower than for patients without PVD (83% to 
86%).is Recent analyses by Eagle et al.i6 confirm the 
role of PVD as an independent risk factor for 
long-term death after CABG. 
Despite increased long-term mortality rates 
compared with patients without PVD undergoing 
CABG, patients with PVD undergoing CABG may 
have improved survival rates relative to patients with 
PVD with severe coronary disease treated medically. 
In an observational study by Hertzer et al.,3 the 
5-year mortality rate was lower in patients undergo- 
ing CABG before repair of abdominal aortic aneu- 
rysms (5%) than in patients with abdominal aortic 
aneurysms who have advanced compensated coro- 
nary disease (11%) or severe uncorrected or inoper- 
able coronary disease (34%) treated medically. To 
date, only one randomized, controlled study allows 
inferences on the effect of PVD on the long-term 
benefit of CABG. In a subgroup of patients with 
PVD participating in the European Coronary Sur- 
gery Study, 28 patients randomized to CABG had 
improved 8-year survival rates relative to the 30 pa- 
tients randomized tomedical therapy (85% vs 57%; 
p = 0.02).  17 Larger, controlled studies will be re- 
quired to assess more precisely the relative benefit of 
CABG according to coronary anatomy, left ventricu- 
lar function, and degree of myocardial ischemia. 
Better understanding o f  the effect of PVD on 
in-hospital deaths with CABG is useful to both 
cardiac surgeons and vascular surgeons. For the 
former, careful assessment of operative risk includes 
consideration of patient age, sex, body surface area, 
ejection fraction, LVEDP, surgical priority, prior 
CABG, and the presence of comorbidity. 6 After 
accounting for these variables, our study suggests 
that he presence of lower extremity occlusive disease, 
including subclinical manifestations such as absent 
pedal pulses, increases operative mortality rates by 
approximately twofold. On the other hand, evidence 
of cerebrovascular disease appears to have little effect 
on operative mortality rates. Knowledge of the effect 
of PVD on operative risks may be especially impor- 
tant when coronary revascularization is being con- 
sidered primarily for symptomatic improvement. 
For vascular surgeons, knowledge of the in- 
creased risks of CABG in patients with PVD may be 
important in decisions to recommend "prophylactic" 
CABG for patients awaiting major peripheral vascu- 
lar surgery who have reconstructible h art disease. 
Despite their high observed mortality rates (5 of 20; 
25%), the small number of patients undergoing 
prophylactic CABG in this series precludes meaning- 
ful direct inferences. However, given the consistently 
elevated CABG-related mortality rates observed in 
patients with broader indicators of PVD, the com- 
bination of CABG and peripheral vascular surgery 
may not be associated with lower short-term risks 
than with performing the peripheral vascular proce- 
dure alone. Final determination f the role of CABG 
in patients with PVD will await carefully controlled 
studies of the long-term benefits of coronary revas- 
cularization i  this population at high risk. 
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